Concerns about data reporting and interpretation in...

Concerns about data reporting and interpretation in “Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial”

David M. Marks, Jonathan S. Abramowitz, Glen I. Spielmans
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
46
Year:
2012
Language:
english
Pages:
2
DOI:
10.1016/j.jpsychires.2012.02.002
File:
PDF, 84 KB
english, 2012
Conversion to is in progress
Conversion to is failed